Rituximab Maintenance Therapy for Marginal Zone B-cell Lymphoma (MZL)
Clinical trial NCT01213095 · COMPLETED
Trial details
- NCT number
- NCT01213095
- Sponsor
- Dong-A University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2013-09-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.